Pharmacology of Parkinson's Disease

Therapeutics of Parkinson's Disease and Other Movement Disorders

Volumn , Issue , 2008, Pages 37-48

  Brotchie, Jonathan M ^a  

^a UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

Basal ganglia; Parkinson's disease; Parkinsonism; PD; Pharmacology; Therapeutics

Indexed keywords

EID: 84891016264     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470713990.ch3     Document Type: Chapter

References (54)

1. Alexander, G.E., Crutcher, M.D. and DeLong, M.R. (1990) Progress in Brain Research, 85, 119-146.
2. Apicella, P. (2007) Trends in Neurosciences, 30, 299-306.
3. Aubert, I., Guigoni, C., Hakansson, K., Li, Q., Dovero, S., Barthe, N., Bioulac, B.H., Gross, C.E., Fisone, G., Bloch, B. and Bezard, E. (2005) Annals of Neurology, 57, 17-26.
4. Bergman, H., Wichmann, T. and DeLong, M.R. (1990) Science, 249, 1436-1438.
5. Bezard, E., Brotchie, J.M. and Gross, C.E. (2001) Nature Reviews. Neuroscience, 2, 577-588.
6. Bezard, E., Baufreton, J., Owens, G., Crossman, A.R., Dudek, H., Taupignon, A. and Brotchie, J.M. (2003a) The FASEB Journal, 17, 2337-2338.
7. Bezard, E., Ferry, S., Mach, U., Stark, H., Leriche, L., Boraud, T., Gross, C. and Sokoloff, P. (2003b) Nature Medicine, 9, 762-767.
8. Bezard, E., Gross, C.E., Qin, L., Gurevich, V.V., Benovic, J.L. and Gurevich, E.V. (2005) Neurobiology of Disease, 18, 323-335.
9. Blanchet, P.J., Konitsiotis, S., Whittemore, E.R., Zhou, Z.L., Woodward, R.M. and Chase, T.N. (1999) The Journal of Pharmacology and Experimental, Therapeutics 290, 1034-1040.
10. Brotchie, J.M. (2005) Movement Disorders, 20, 919-931.
11. Calon, F., Rajput, A.H., Hornykiewicz, O., Bedard, P.J. and Di Paolo, T. (2003) Neurobiology of Disease, 14, 404-416.
12. Cenci, M.A. (2007) Trends in Neurosciences, 30, 236-243.
13. Chen, L., Yung, K.K. and Yung, W.H. (2006) Neuroscience, 141, 1871-1878.
14. Cragg, S.J. (2006) Trends in Neurosciences, 29, 125-131.
15. Diaz-Cabiale, Z., Vivo, M., Del Arco, A., O'Connor, W.T., Harte, M.K., Muller, C.E., Martinez, E., Popoli, P., Fuxe, K. and Ferre, S. (2002) Neuroscience Letters, 324, 154-158.
16. Dunah, A.W., Wang, Y., Yasuda, R.P., Kameyama, K., Huganir, R.L., Wolfe, B.B. and Standaert, D.G. (2000) Molecular Pharmacology, 57, 342-352.
17. Fuxe, K., Agnati, L.F., Jacobsen, K., Hillion, J., Canals, M., Torvinen, M., Tinner-Staines, B., Staines, W., Rosin, D., Ter-asmaa, A., Popoli, P., Leo, G., Vergoni, V., Lluis, C., Ciruela, F., Franco, R. and Ferre, S. (2003) Neurology, 61, S19-S23.
18. Guigoni, C., Doudnikoff, E., Li, Q., Bloch, B. and Bezard, E. (2007) Neurobiology of Disease, 26, 452-463.
19. Hadj Tahar, A., Gregoire, L., Darre, A., Belanger, N., Meltzer, L. and Bedard, P.J. (2004) Neurobiology of Disease, 15, 171-176.
20. Hallett, P.J., Dunah, A.W., Ravenscroft, P., Zhou, S., Bezard, E., Crossman, A.R., Brotchie, J.M. and Standaert, D.G. (2005) Neuropharmacology, 48, 503-516.
21. Hamada, M., Higashi, H., Nairn, A.C., Greengard, P. and Nishi, A. (2004) Journal of Neurochemistry, 90, 1094-1103.
22. Ince, E., Ciliax, B.J. and Levey, A.I. (1997) Synapse, 27, 357-366.
23. Jackson, M.J., Smith, L.A., Al-Barghouthy, G., Rose, S. and Jenner, P. (2007) Experimental Neurology, 204, 162-170.
24. Jenner, P. (2003) Neurology, 61, S32-S38.
25. Kanda, T., Jackson, M.J., Smith, L.A., Pearce, R.K., Nakamura, J., Kase, H., Kuwana, Y. and Jenner, P. (1998) Annals of Neurology, 43, 507-513.
26. Kreitzer, A.C. and Malenka, R.C. (2007) Nature, 445, 643-647.
27. Loschmann, P.A., De Groote, C., Smith, L., Wullner, U., Fischer, G., Kemp, J.A., Jenner, P. and Klockgether, T. (2004) Experimental Neurology, 187, 86-93.
28. Maccarrone, M., Gubellini, P., Bari, M., Picconi, B., Battista, N., Centonze, D., Bernardi, G., Finazzi-Agro, A. and Calabresi, P. (2003) Journal of Neurochemistry, 85, 1018-1025.
29. Martorana, A., Martella, G., D'Angelo, V., Fusco, F.R., Spadoni, F., Bernardi, G. and Stefani, A. (2006) Synapse, 60, 371-383.
30. Maurice, N., Mercer, J., Chan, C.S., Hernandez-Lopez, S., Held, J., Tkatch, T. and Surmeier, D.J. (2004) The Journal of Neuroscience, 24, 10289-10301.
31. Mitchell, I.J., Cross, A.J., Sambrook, M.A. and Crossman, A.R. (1986) Neuroscience Letters, 63, 61-65.
32. Mitchell, I.J., Clarke, C.E., Boyce, S., Robertson, R.G., Peggs, D., Sambrook, M.A. and Crossman, A.R. (1989) Neuroscience, 32, 213-226.
33. Narushima, M., Hashimoto, K. and Kano, M. (2006) Neuroscience Research, 54, 159-164.
34. Narushima, M., Uchigashima, M., Fukaya, M., Matsui, M., Manabe, T., Hashimoto, K., Watanabe, M. and Kano, M. (2007) The Journal of Neuroscience, 27, 496-506.
35. Nash, J.E. and Brotchie, J.M. (2002) Movement Disorders, 17, 455-466.
36. Nash, J.E., Hill, M.P. and Brotchie, J.M. (1999) Experimental Neurology, 155, 42-48.
37. Nash, J.E., Fox, S.H., Henry, B., Hill, M.P., Peggs, D., McGuire, S., Maneuf, Y., Hille, C., Brotchie, J.M. and Crossman, A.R. (2000) Experimental Neurology, 165, 136-142.
38. Obeso, J.A., Rodriguez, M.C. and DeLong, M.R. (1997) Advances in Neurology, 74, 3-18.
39. Obeso, J.A., Rodriguez-Oroz, M.C., Rodriguez, M., DeLong, M.R. and Olanow, C.W. (2000) Annals of Neurology, 47, S22-S32; discussion S32-4.
40. Pearce, R.K., Banerji, T., Jenner, P. and Marsden, C.D. (1998) Movement Disorders, 13, 234-241.
41. Penney, J.B. Jr and Young, A.B. (1986) Movement Disorders, 1, 3-15.
42. Pisani, A., Bonsi, P., Picconi, B., Tolu, M., Giacomini, P. and Scarnati, E. (2001) Progress in Neuro-Psychopharmacology & Biological Psychiatry 25, 211-230.
43. Pisani, A., Fezza, F., Galati, S., Battista, N., Napolitano, S., Finazzi-Agro, A., Bernardi, G., Brusa, L., Pierantozzi, M., Stanzione, P. and Maccarrone, M. (2005) Annals of Neurology, 57, 777-779.
44. Sanchez-Lemus, E. and Arias-Montano, J.A. (2006) Neurochemi-cal Research, 31, 555-561.
45. Savola, J.M., Hill, M., Engstrom, M., Merivuori, H., Wurster, S., McGuire, S.G., Fox, S.H., Crossman, A.R. and Brotchie, J.M. (2003) Movement Disorders, 18, 872-883.
46. Schwarzschild, M.A., Agnati, L., Fuxe, K., Chen, J.F. and Morelli, M. (2006) Trends in Neurosciences, 29, 647-654.
47. Silverdale, M.A., Nicholson, S.L., Ravenscroft, P., Crossman, A. R., Millan, M.J. and Brotchie, J.M. (2004) Experimental Neurology, 188, 128-138.
48. Silverdale, M.A., Nicholson, S.L., Crossman, A.R. and Brotchie, J.M. (2005) Movement Disorders, 20, 403-409.
49. Smith, L.A., Jackson, M.J., Hansard, M.J., Maratos, E. and Jenner, P. (2003) Movement Disorders, 18, 487-495.
50. Smith, L.A., Jackson, M.J., Johnston, L., Kuoppamaki, M., Rose, S., Al-Barghouthy, G., Del Signore, S. and Jenner, P. (2006) Clinical Neuropharmacology, 29, 112-125.
51. Steece-Collier, K., Chambers, L.K., Jaw-Tsai, S.S., Menniti, F.S. and Greenamyre, J.T. (2000) Experimental Neurology, 163, 239-243.
52. van der Stelt, M., Fox, S.H., Hill, M., Crossman, A.R., Petrosino, S., Di Marzo, V. and Brotchie, J.M. (2005) The FASEB Journal, 19, 1140-1142.
53. Wessell, R.H., Ahmed, S.M., Menniti, F.S., Dunbar, G.L., Chase, T.N. and Oh, J.D. (2004) Neuropharmacology, 47, 184-194.
54. Wichmann, T. and DeLong, M.R. (1999) Nature, 400, 621-622.